| Financial Year |
March 31 2023 |
| Monetary Funds |
75,337,857.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,894,000.00 |
| Accounts Receivable |
1,473,544,068.65 |
| Advances to Suppliers |
3,248,277.97 |
| Other Receivables |
11,808,691.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,367,591.30 |
| Inventories |
59,688,308.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,479,965.62 |
| Total Current Assets |
1,662,601,169.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,320,674.30 |
| Investment Properties |
40,171,077.47 |
| Fixed Assetes |
5,389,425,726.85 |
| Under-construction Projects |
286,481,934.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,809,949.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,465,005.73 |
| Deferred Income Tax Assets |
47,714,249.64 |
| Other Non-Current Assets |
60,712,974.81 |
| Sub-Total of Non-Current Assets |
5,998,131,497.24 |
| Total Assets |
7,660,732,666.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
142,634,190.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,969,222.07 |
| Taxes Payable |
24,496,496.47 |
| Interest Payable |
-- |
| Dividend Payable |
3,056,612.84 |
| Other payables |
2,215,550,387.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
335,290,519.02 |
| Other Current Liabilities |
5,793,559.00 |
| Sub-Total of Current Liabilities |
2,729,173,787.25 |
| Long-term Loans |
1,876,545,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
23,225,084.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,925,465,898.45 |
| Total Liabilities |
4,654,639,685.70 |
| Paid-In Capital(Or Share Stock) |
706,118,997.00 |
| Capital Surplus |
2,679,065,956.21 |
| Surplus Reserve |
24,499,326.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-478,473,260.26 |
| Minority Stockholder's Interest |
71,316,081.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,934,776,899.67 |
| Owner's Equity（Stockholder's Equity） |
3,006,092,980.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,660,732,666.46 |
